学术界SARS-CoV-2免疫指数:疫苗接种后的回顾性研究

IF 3.4 Q2 INFECTIOUS DISEASES
Keltyn Oliveira, Ana Almeida, Carina Silva, Miguel Brito, Edna Ribeiro
{"title":"学术界SARS-CoV-2免疫指数:疫苗接种后的回顾性研究","authors":"Keltyn Oliveira, Ana Almeida, Carina Silva, Miguel Brito, Edna Ribeiro","doi":"10.3390/idr16060088","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/objectives: </strong>The COVID-19 pandemic has revolutionized vaccine production and compelled a massive global vaccination campaign. This study aimed to estimate the positivity and levels of SARS-CoV-2 IgG antibodies acquired due to vaccination and infection in the academic population of a Portuguese university.</p><p><strong>Methods: </strong>Blood samples were collected and analyzed through the ELISA methodology, and statistical analysis was performed.</p><p><strong>Results: </strong>A total of 529 volunteers with at least one dose of the vaccine were enrolled in this study. Individuals without a prior COVID-19 diagnosis were divided into two groups: 350, who received a full vaccination, and 114, who received a full vaccination and a booster dose of the same vaccine (81) and mixed vaccines (33). Regarding the individuals who reported a prior SARS-CoV-2 infection, 31 received a full vaccination, and 34 received only one vaccination dose. Data analysis showed a higher level of IgG against SARS-CoV-2 in individuals who were younger, female, who received the Moderna vaccine, with recent post-vaccine administration, a mixed booster dose, and prior SARS-CoV-2 infection.</p><p><strong>Conclusions: </strong>Assessing vaccination's effectiveness and group immunity is crucial for pandemic management, particularly in academic environments with high individual mobility, in order to define groups at risk and redirect infection control strategies.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1084-1097"},"PeriodicalIF":3.4000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675320/pdf/","citationCount":"0","resultStr":"{\"title\":\"SARS-CoV-2 Immunization Index in the Academic Community: A Retrospective Post-Vaccination Study.\",\"authors\":\"Keltyn Oliveira, Ana Almeida, Carina Silva, Miguel Brito, Edna Ribeiro\",\"doi\":\"10.3390/idr16060088\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/objectives: </strong>The COVID-19 pandemic has revolutionized vaccine production and compelled a massive global vaccination campaign. This study aimed to estimate the positivity and levels of SARS-CoV-2 IgG antibodies acquired due to vaccination and infection in the academic population of a Portuguese university.</p><p><strong>Methods: </strong>Blood samples were collected and analyzed through the ELISA methodology, and statistical analysis was performed.</p><p><strong>Results: </strong>A total of 529 volunteers with at least one dose of the vaccine were enrolled in this study. Individuals without a prior COVID-19 diagnosis were divided into two groups: 350, who received a full vaccination, and 114, who received a full vaccination and a booster dose of the same vaccine (81) and mixed vaccines (33). Regarding the individuals who reported a prior SARS-CoV-2 infection, 31 received a full vaccination, and 34 received only one vaccination dose. Data analysis showed a higher level of IgG against SARS-CoV-2 in individuals who were younger, female, who received the Moderna vaccine, with recent post-vaccine administration, a mixed booster dose, and prior SARS-CoV-2 infection.</p><p><strong>Conclusions: </strong>Assessing vaccination's effectiveness and group immunity is crucial for pandemic management, particularly in academic environments with high individual mobility, in order to define groups at risk and redirect infection control strategies.</p>\",\"PeriodicalId\":13579,\"journal\":{\"name\":\"Infectious Disease Reports\",\"volume\":\"16 6\",\"pages\":\"1084-1097\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-11-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675320/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious Disease Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/idr16060088\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Disease Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/idr16060088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景/目标:2019冠状病毒病大流行彻底改变了疫苗生产,迫使全球开展大规模疫苗接种运动。本研究旨在估计葡萄牙一所大学学术人群因接种疫苗和感染而获得的SARS-CoV-2 IgG抗体的阳性和水平。方法:采用ELISA法采集血样进行分析,并进行统计学分析。结果:共有529名至少接种了一剂疫苗的志愿者参加了这项研究。之前没有COVID-19诊断的个体被分为两组:350人接受了全面疫苗接种,114人接受了全面疫苗接种和同一疫苗的加强剂(81人)和混合疫苗(33人)。在报告先前感染过SARS-CoV-2的个体中,31人接受了完整的疫苗接种,34人只接受了一剂疫苗接种。数据分析显示,年轻、女性、接种现代疫苗、近期接种疫苗后、混合加强剂量和既往感染过SARS-CoV-2的个体中,针对SARS-CoV-2的IgG水平较高。结论:评估疫苗接种的有效性和群体免疫对于大流行管理至关重要,特别是在个人流动性高的学术环境中,以便确定有风险的群体并重新制定感染控制策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
SARS-CoV-2 Immunization Index in the Academic Community: A Retrospective Post-Vaccination Study.

Background/objectives: The COVID-19 pandemic has revolutionized vaccine production and compelled a massive global vaccination campaign. This study aimed to estimate the positivity and levels of SARS-CoV-2 IgG antibodies acquired due to vaccination and infection in the academic population of a Portuguese university.

Methods: Blood samples were collected and analyzed through the ELISA methodology, and statistical analysis was performed.

Results: A total of 529 volunteers with at least one dose of the vaccine were enrolled in this study. Individuals without a prior COVID-19 diagnosis were divided into two groups: 350, who received a full vaccination, and 114, who received a full vaccination and a booster dose of the same vaccine (81) and mixed vaccines (33). Regarding the individuals who reported a prior SARS-CoV-2 infection, 31 received a full vaccination, and 34 received only one vaccination dose. Data analysis showed a higher level of IgG against SARS-CoV-2 in individuals who were younger, female, who received the Moderna vaccine, with recent post-vaccine administration, a mixed booster dose, and prior SARS-CoV-2 infection.

Conclusions: Assessing vaccination's effectiveness and group immunity is crucial for pandemic management, particularly in academic environments with high individual mobility, in order to define groups at risk and redirect infection control strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Infectious Disease Reports
Infectious Disease Reports INFECTIOUS DISEASES-
CiteScore
5.10
自引率
0.00%
发文量
82
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信